Tag Archives: About

What’s BMS saying about its Celgene buy behind the scenes? This transcript tells all

Bristol-Myers Squibb CEO Giovanni Caforio has friends on TV now. R&D chief Tom Lynch has done some of his CAR-T due diligence on YouTube. And one reason Celgene was interested in Bristol’s $ 74 billion buyout bid is that its own rollout of psoriasis drug Otezla was, well, pretty lame. A fly on the wall… Read More »

What You Need To Know About Supplements

  Americans spend about $ 37 billion dollars a year on nutritional supplements. These range from vitamins and minerals to sleeping aids, memory enhancers and disease cures. The proportion of adults using a supplement of some kind rose from 51.8% in 2005 to 63.7% IN 2011, and this number is increasing yearly. These numbers represent… Read More »